Sanchez, Kate B.
HRN: 29-19-82 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/28/2026
MUPIROCIN 2%, 15G (TUBE)
07/30/2026
08/03/2026
DERMAL
2%
OD
Sp 1 LTCS
Pending Pharmacy Acceptance
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: